Download full-text PDF

Source
http://dx.doi.org/10.5694/j.1326-5377.1969.tb62350.xDOI Listing

Publication Analysis

Top Keywords

rubella serological
4
serological survey
4
survey pregnant
4
pregnant patients
4
patients melbourne
4
melbourne 1968
4
rubella
1
survey
1
pregnant
1
patients
1

Similar Publications

Objective: Childhood cancer treatment disrupts vaccination schedules and weakens or eliminates vaccine-induced immunity. In addition, post-treatment vaccine responses vary. This study aimed to assess post-treatment serum antibody levels and vaccine responses in children.

View Article and Find Full Text PDF

The postpartum period provides an opportunity to improve maternal and infant health, including identifying risks and completing immunization series. Research on completion of varicella and measles, mumps, and rubella (MMR) vaccine series among postpartum mothers is limited. This study examined data from mothers with public health insurance who received prenatal and postpartum care at the Mount Sinai Health System between January 1, 2021, and June 27, 2022.

View Article and Find Full Text PDF
Article Synopsis
  • Residual blood specimens offer a cost-effective way to track seroprevalence changes compared to traditional household surveys, as shown in a study in India focused on measles-rubella vaccinations.
  • A cross-sectional survey in Kanpur Nagar and Palghar found significant increases in rubella seroprevalence post-immunization, though measles trends were inconsistent between facility and community samples.
  • Younger children in public facilities initially had lower rubella seroprevalence than those in private hospitals, but this gap disappeared after the vaccination campaign, highlighting the importance of residual specimens for public health monitoring.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigated the effectiveness of TORCH serology testing in pregnant women with suspected infections based on clinical signs, focusing on maternal versus fetal-related reasons for testing.
  • Over 10 years, researchers analyzed data from 1,075 women, finding higher rates of TORCH infections, particularly cytomegalovirus (CMV), in those tested for maternal-related symptoms compared to those tested for fetal-related symptoms.
  • The results suggest that while the overall benefits of TORCH testing for fetal issues were low, maternal symptoms should prompt testing, especially for CMV and Toxoplasma infections.
View Article and Find Full Text PDF

Background: Serodiagnosis of TORCH infections should be performed in pre-pregnancy and reproductive-age women to prevent vertical transmission. Herein, we conducted a 5-year cross-sectional retrospective study in childbearing age women to provide prevalence data. Also, stratifying the cohort into three age groups, we identified those most susceptible to acute TORCH infections.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!